Follow
Julia Kodysh
Julia Kodysh
OpenVax @ Icahn School of Medicine at Mount Sinai
Verified email at openvax.org
Title
Cited by
Cited by
Year
Immunology of COVID-19: current state of the science
N Vabret, GJ Britton, C Gruber, S Hegde, J Kim, M Kuksin, R Levantovsky, ...
Immunity 52 (6), 910-941, 2020
14812020
Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction
DK Wells, MM van Buuren, KK Dang, VM Hubbard-Lucey, KCF Sheehan, ...
Cell 183 (3), 818-834. e13, 2020
1772020
Google correlate whitepaper
M Mohebbi, D Vanderkam, J Kodysh, R Schonberger, H Choi, S Kumar
872011
Computational pipeline for the PGV-001 neoantigen vaccine trial
A Rubinsteyn, J Kodysh, I Hodes, S Mondet, BA Aksoy, JP Finnigan, ...
Frontiers in immunology 8, 1807, 2018
412018
Landscape and selection of vaccine epitopes in SARS-CoV-2
CC Smith, KS Olsen, KM Gentry, M Sambade, W Beck, J Garness, ...
Genome medicine 13 (1), 1-23, 2021
282021
Bioinformatic methods for cancer neoantigen prediction
S Boegel, JC Castle, J Kodysh, T O'Donnell, A Rubinsteyn
Progress in molecular biology and translational science 164, 25-60, 2019
202019
Mutations in an innate immunity pathway are associated with poor overall survival outcomes and hypoxic signaling in cancer
MM Olcina, NG Balanis, RK Kim, BA Aksoy, J Kodysh, MJ Thompson, ...
Cell reports 25 (13), 3721-3732. e6, 2018
182018
Vaxrank: a computational tool for designing personalized cancer vaccines
A Rubinsteyn, I Hodes, J Kodysh, J Hammerbacher
bioRxiv, 142919, 2018
172018
OpenVax: an open-source computational pipeline for cancer neoantigen prediction
J Kodysh, A Rubinsteyn
Bioinformatics for Cancer Immunotherapy, 147-160, 2020
132020
Google correlate whitepaper. 2011
M Mohebbi, D Vanderkam, J Kodysh, R Schonberger, H Choi, S Kumar
102011
Immunology of COVID-19: current state of the science
M Agrawal, M Aleynick, M Belabed, G Britton, M Brown, ...
22020
A phase I study of the safety and immunogenicity of a multi-peptide personalized genomic vaccine in the adjuvant treatment of solid tumors and hematological malignancies.
A Blazquez, A Rubinsteyn, J Kodysh, JP Finnigan, TU Marron, M Meseck, ...
Journal of Clinical Oncology 37 (15_suppl), e14307-e14307, 2019
22019
Abstract LB048: An adjuvant personalized neoantigen peptide vaccine for the treatment of malignancies (PGV-001)
TU Marron, M Saxena, N Bhardwaj, M Meseck, A Rubinsteyn, J Finnigan, ...
Cancer Research 81 (13_Supplement), LB048-LB048, 2021
12021
CTIM-17. PHASE I STUDY OF THE SAFETY AND IMMUNOGENICITY OF PERSONALIZED NEOANTIGEN VACCINES AND TUMOR TREATING FIELDS IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
J Kodysh, A Rubinsteyn, A Blazquez, J Mandeli, N Bhardwaj, A Hormigo
Neuro-Oncology 22 (Suppl 2), ii36, 2020
12020
289 PGV-001: a phase 1 trial of a personalized neoantigen peptide vaccine for the treatment of malignancies in the adjuvant setting
T Marron, J Kodysh, A Rubinsteyn, J Finnigan, A Blazquez, M Saxena, ...
Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020
12020
Abstract CT062: A Phase I study of the safety and immunogenicity of personalized mutation-derived tumor vaccine and treatment fields in patients with newly diagnosed glioblastoma
A Hormigo, A Rubinsteyn, J Kodysh, A Blazquez, N Bhardwaj
Cancer Research 79 (13_Supplement), CT062-CT062, 2019
12019
Association between Incidental Pelvic Inflammation and Aggressive Prostate Cancer
D Chakravarty, P Ratnani, L Huang, Z Dovey, S Sobotka, R Berryhill, ...
Cancers 14 (11), 2734, 2022
2022
334 Phase I study of safety and activity of personalized neoantigen-based vaccines in combination with tumor treating fields for newly diagnosed glioblastoma patients
A Hormigo, J Kodysh, CC Bozkus, M Saxena, M Meseck, A Rubinsteyn, ...
J Immunother 9 (2), A1-A1054, 2021
2021
EPCO-22. IDENTIFYING NEOANTIGENS FOR A PERSONALIZED MUTATION-DERIVED GENOMIC VACCINE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
J Kodysh, A Rubinsteyn, A Blazquez, J Mandeli, N Bhardwaj, A Hormigo
Neuro-Oncology 22 (Suppl 2), ii73, 2020
2020
IDENTIFYING NEOANTIGENS FOR A PERSONALIZED MUTATION-DERIVED GENOMIC VACCINE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
J Kodysh, A Rubinsteyn, A Blazquez, J Mandeli, N Bhardwaj, A Hormigo
NEURO-ONCOLOGY 22, 74-74, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20